Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001080839 | SCV000285266 | benign | Tuberous sclerosis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000231071 | SCV000518099 | likely benign | not provided | 2021-06-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28385778) |
Ambry Genetics | RCV000576038 | SCV000675464 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000231071 | SCV001150699 | uncertain significance | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000231071 | SCV001476296 | likely benign | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001080839 | SCV002039601 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000576038 | SCV002531024 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-04 | criteria provided, single submitter | curation |